We previously identified MT1-MMP as a target of HIF-2α [23], and our current data show that expression of HIF-2α in a wild-type VHL background induces the ability of the RCC cells to degrade type I collagen (see Figure 2A). The gene discussed is EPAS1; the disease is renal cell carcinoma.